Bertrand Favier

2.1k total citations
49 papers, 1.6k citations indexed

About

Bertrand Favier is a scholar working on Molecular Biology, Rheumatology and Nuclear and High Energy Physics. According to data from OpenAlex, Bertrand Favier has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Rheumatology and 9 papers in Nuclear and High Energy Physics. Recurrent topics in Bertrand Favier's work include Nuclear physics research studies (8 papers), Nuclear Physics and Applications (7 papers) and Urticaria and Related Conditions (6 papers). Bertrand Favier is often cited by papers focused on Nuclear physics research studies (8 papers), Nuclear Physics and Applications (7 papers) and Urticaria and Related Conditions (6 papers). Bertrand Favier collaborates with scholars based in France, Switzerland and United States. Bertrand Favier's co-authors include Pascal Dollé, Pierre Chambon, Catherine Fromental-Ramain, Jacques Thélu, Patricia Rossio, Herbert Haack, Xavier Warot, Andrée Dierich, Pierre Chambon and M Le Meur and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Bertrand Favier

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bertrand Favier France 18 812 277 276 133 121 49 1.6k
B. Saitta United States 21 512 0.6× 194 0.7× 210 0.8× 140 1.1× 17 0.1× 65 1.3k
I. Nakamura Japan 20 1.1k 1.3× 141 0.5× 114 0.4× 27 0.2× 72 0.6× 96 2.2k
J. McGill United States 21 615 0.8× 379 1.4× 215 0.8× 81 0.6× 6 0.0× 52 1.5k
Kenneth A. Frankel United States 29 630 0.8× 300 1.1× 61 0.2× 206 1.5× 18 0.1× 68 2.8k
Tohru Itoh Japan 36 2.0k 2.5× 56 0.2× 317 1.1× 258 1.9× 37 0.3× 79 4.1k
Takashi Ariizumi Japan 21 794 1.0× 65 0.2× 174 0.6× 17 0.1× 10 0.1× 93 1.3k
Marcus Settles Germany 28 630 0.8× 45 0.2× 93 0.3× 150 1.1× 19 0.2× 56 2.3k
Eiichi Konishi Japan 24 459 0.6× 88 0.3× 78 0.3× 20 0.2× 14 0.1× 204 2.2k
Janet Hall France 33 2.6k 3.2× 32 0.1× 428 1.6× 79 0.6× 9 0.1× 74 4.4k
Koji Tamura Japan 20 741 0.9× 238 0.9× 212 0.8× 11 0.1× 9 0.1× 75 1.4k

Countries citing papers authored by Bertrand Favier

Since Specialization
Citations

This map shows the geographic impact of Bertrand Favier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand Favier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand Favier more than expected).

Fields of papers citing papers by Bertrand Favier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand Favier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand Favier. The network helps show where Bertrand Favier may publish in the future.

Co-authorship network of co-authors of Bertrand Favier

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand Favier. A scholar is included among the top collaborators of Bertrand Favier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand Favier. Bertrand Favier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Drevet, Sabine, Bertrand Favier, Bernard Lardy, G. Gavazzi, & Emmanuel Brun. (2022). New imaging tools for mouse models of osteoarthritis. GeroScience. 44(2). 639–650. 8 indexed citations
2.
Favier, Bertrand, Thomas Stoeger, Amanda Capes‐Davis, et al.. (2022). Identification of human gene research articles with wrongly identified nucleotide sequences. Life Science Alliance. 5(4). e202101203–e202101203. 19 indexed citations
3.
Fontaine, Emeline, Christophe Papin, Guillaume Martinez, et al.. (2022). Dual role of histone variant H3.3B in spermatogenesis: positive regulation of piRNA transcription and implication in X-chromosome inactivation. Nucleic Acids Research. 50(13). 7350–7366. 10 indexed citations
4.
5.
Baillet, Athan, Claire Douillard, Charles W. Armitage, et al.. (2017). Chlamydia-Infected Macrophages: "Trojan Horses" for Dissemination of IL-23 and TNF-Mediated Inflammation in SKG Mouse Reactive Arthritis. Queensland's institutional digital repository (The University of Queensland). 69. 1 indexed citations
6.
Defendi, Federica, et al.. (2016). Kininogen Cleavage Assay: Diagnostic Assistance for Kinin-Mediated Angioedema Conditions. PLoS ONE. 11(9). e0163958–e0163958. 17 indexed citations
7.
8.
Ghannam, Arije, et al.. (2013). Contact System Activation in Patients with HAE and Normal C1 Inhibitor Function. Immunology and Allergy Clinics of North America. 33(4). 513–533. 8 indexed citations
9.
Péron, Julien, Olivier Trédan, Isabelle Ray‐Coquard, et al.. (2012). First-line endocrine therapy alone could be a reasonable treatment option for hormone-positive, HER2-positive metastatic breast cancer. Bulletin du Cancer. 99(2). E18–E25. 2 indexed citations
10.
Favier, Bertrand, Annie Valette, Caroline Barette, et al.. (2009). Benzo[e]pyridoindoles,  novel inhibitors of the Aurora kinases. Cell Cycle. 8(5). 765–772. 15 indexed citations
11.
Fayette, Jérôme, Helen Boyle, Sylvie Chabaud, et al.. (2009). Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution. Anti-Cancer Drugs. 21(1). 113–119. 22 indexed citations
12.
Dumestre‐Pérard, Chantal, Nicole M. Thielens, Bertrand Favier, et al.. (2007). Activation of classical pathway of complement cascade by soluble oligomers of prion. Cellular Microbiology. 9(12). 2870–2879. 12 indexed citations
13.
Favier, Bertrand, et al.. (2003). [Immediate hypersensitivity is rarely implicated in drug induced urticaria].. PubMed. 130(3). 321–4. 12 indexed citations
14.
Favetta, Patrick, et al.. (2002). Comparison of ceftazidime degradation in glass bottles and plastic bags under various conditions. Journal of Clinical Pharmacy and Therapeutics. 27(3). 205–209. 16 indexed citations
15.
Thélu, Jacques, Patricia Rossio, & Bertrand Favier. (2002). Notch signalling is linked to epidermal cell differentiation level in basal cell carcinoma, psoriasis and wound healing. BMC Dermatology. 2(1). 7–7. 131 indexed citations
16.
Phillips, Keith, et al.. (2001). [Drug-induced urticaria].. PubMed. 128(10 Pt 2). 1166–73. 1 indexed citations
17.
Favier, Bertrand. (1997). Developmental functions of mammalian Hox genes. Molecular Human Reproduction. 3(2). 115–131. 179 indexed citations
18.
Zákány, József, Matthieu Gérard, Bertrand Favier, S. Steven Potter, & Denis Duboule. (1996). Functional Equivalence and Rescue Among Group 11HoxGene Products in Vertebral Patterning. Developmental Biology. 176(2). 325–328. 47 indexed citations
19.
Favier, Bertrand, et al.. (1990). Bacteriological study of 58 strains of Corynebacterium pseudotuberculosis. 2. Sensitivity to antibiotics.. Revue Méd Vét. 141(10). 743–748. 2 indexed citations
20.
Schwaller, P., Bertrand Favier, D.F. Measday, et al.. (1972). PROTON TOTAL CROSS SECTIONS ON $sup 1$H, $sup 2$D, $sup 4$He, $sup 12$C, AND $sup 16$O IN THE ENERGY RANGE 180 TO 560 MeV.. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Saitta Breakdown of academic impact, for papers by I. Nakamura Breakdown of academic impact, for papers by J. McGill Breakdown of academic impact, for papers by Kenneth A. Frankel Breakdown of academic impact, for papers by Tohru Itoh Breakdown of academic impact, for papers by Takashi Ariizumi Breakdown of academic impact, for papers by Marcus Settles Breakdown of academic impact, for papers by Eiichi Konishi Breakdown of academic impact, for papers by Janet Hall Breakdown of academic impact, for papers by Koji Tamura
Rankless by CCL
2026